Director, Patient Focused Drug Development Program, OCD, CDER, FDA, United States
Robyn Bent is the director of CDER’s Patient-Focused Drug Development (PFDD) Program, an effort to systematically obtain patient input and facilitate the incorporation of meaningful patient input into drug development and regulatory decision making. Prior to joining FDA, Robyn was...
Read More →
Senior Clinical Analyst for Stakeholder Engagement, ON, OND, CDER, FDA, United States
Michelle Campbell is the Sr. Clinical Analyst for Stakeholder Engagement and Clinical Outcomes in the Office of Neuroscience, Office of New Drugs (OND), Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA). Previously, Dr. Campbell was a reviewer...
Read More →
Vice President, Clinical Science, PepGen Inc., United States
Jane Larkindale is Vice President of Clinical Science at PepGen, a company developing enhanced delivery oligonucleotide therapeutics for Duchenne muscular dystrophy and myotonic dystrophy. She has dedicated the past 15 years to accelerating therapy development for rare diseases, with...
Read More →KR
Chief Scientific Officer, Critical Path Institute (C-Path), United States
Klaus Romero MD, MS, FCP is a clinical pharmacologist and epidemiologist by training, with 15 years combined experience in academic clinical research. Dr. Romero has been with C-Path since December of 2007, and during his tenure, he has helped lead clinical pharmacology, pharmacoepidemiology...
Read More → 
Create a custom schedule.
Take it with you on mobile.
Get listed in the directory.
